Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
In this phase II study, an investigative (not approved by the FDA) drug called GPI 1485 is
being assessed to see if it can help preserve erectile function after prostatectomy.